Literature DB >> 174366

The stimulation of growth hormone release by ACTH and its inhibition by somatostatin.

J Köbberling, H Jüppner, R D Hesch.   

Abstract

The rapid injection of 0.5 or 1.0 mg of tetracosacitid (Synacthen¿) was followed by a distinct increase of plasma growth hormone (GH) within 30 or 45 min in 5 of 7 normal volunteers. A second control test was performed in 3 of the 5 "responders" and 1 "non-responder" and showed a consistent reaction in all of them. The tests were then repeated in the 5 "responders" during an infusion of somatostatin (150 mug/h) and the GH response was totally abolished (3 subjects) or markedly reduced (2 subjects). Thus the ACTH induced GH release behaves in a manner similar to most other physiological or pharmacological stimuli of GH release. The cortisol output after ACTH was not altered by somatostatin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 174366     DOI: 10.1530/acta.0.0810263

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  Growth hormone (GH) and GH-releasing hormone response to ACTH 1-17 at different times of day. Evidence of a circadian stage dependence.

Authors:  Y Touitou; P Garnier; A Reinberg; L Castagno; M Donnadieu; A Bogdan; Y Motohashi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Somatostatin--both hormone and neurotransmitter?

Authors:  R Luft; S Efendić; T Hökfelt
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

3.  ACTH 1-17 stimulates GH pituitary secretion in humans.

Authors:  G Valenti; A Banchini; L Denti; R Polotti; G P Ceda
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

4.  Suppression and stimulation of growth hormone release in sheep by somatostatin analogs.

Authors:  C Redekopp; J Livesey; R A Donald
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.